Stimcell Energetics Inc. 10-Q

Financial Statements (unaudited)

Item 1. Financial Statements The accompanying unaudited condensed consolidated financial statements of Stimcell Energetics Inc. as at February 28, 2026, have been prepared by the Company’s management in conformity with accounting principles generally accepted in the United States of America and in accordance with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X and, therefore, do not include all information and footnotes necessary for a complete presentation of financial position, results of operations, cash flows, and stockholders’ deficit in conformity with generally accepted accounting principles. In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations and financial position have been included and all such adjustments are of a normal recurring nature. Operating results for the three and nine months ended February 28, 2026, are not necessarily indicative of the results that can be expected for the year ending May 31, 2026. As used in this Quarterly Report, the terms “we,” “us,” “our,” “Stimcell,” “Stimcell Energetics,” and the “Company” mean Stimcell Energetics Inc. and its subsidiary, Cell MedX (Canada) Corp., unless otherwise indicated. All dollar amounts in this Quarterly Report are expressed in U.S. dollars. 1 STIMCELL ENERGETICS INC. CONDENSED CONSOLIDATED BALANCE SHEETS (EXPRESSED IN US DOLLARS) (UNAUDITED) February 28, 2026 May 31, 2025 ASSETS Current assets Cash $ 10,257 $ 14,581 Other current assets 24,264 6,641 Total assets $ 34,521 $ 21,222 LIABILITIES AND STOCKHOLDERS’ DEFICIT Liabilities Accounts payable $ 319,927 $ 322,144 Accrued liabilities 7,791 26,954 Due to related parties 605,231 448,536 Notes and advances due to related parties 779,992 469,874 Total liabilities 1,712,941 1,267,508 STOCKHOLDERS’ DEFICIT Common stock, $ 0.001 par value, 500,000,000 shares authorized; 20,891,272 and 20,141,272 shares issued and outstanding at February 28, 2026 and May 31, 2025, respectively 20,891 20,141 Additional paid-in capital 9,395,841 9,146,591 Reserves 366,493 366,493 Accumulated deficit ( 11,527,472 ) ( 10,861,556 ) Accumulated other comprehensive income 65,827 82,045 Total stockholders’ deficit ( 1,678,420 ) ( 1,246,286 ) Total liabilities and stockholders’ deficit $ 34,521 $ 21,222 The accompanying notes are an integral part of these condensed consolidated financial sta